Targeted Therapy in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the commonest cancers worldwide, as well as a common cause of cancer-related death. HCC frequently occurs in the setting of a diseased cirrhotic liver and many patients present at an advanced stage of disease. Together with a poor functional status, this ofte...
Saved in:
Main Authors: | Clarinda W. L. Chua, Su Pin Choo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | International Journal of Hepatology |
Online Access: | http://dx.doi.org/10.4061/2011/348297 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Bridging Therapy in Hepatocellular Carcinoma
by: Roberto Galuppo, et al.
Published: (2013-01-01) -
Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma
by: Zhigang Ren, et al.
Published: (2020-01-01) -
Exploring Glypican-3 targeted CAR-NK treatment and potential therapy resistance in hepatocellular carcinoma.
by: Lei Yang, et al.
Published: (2025-01-01) -
Emerging nanomedicine strategies for hepatocellular carcinoma therapy
by: Chen Guo, et al.
Published: (2024-09-01) -
Comprehensive analysis of publications concerning combinations of immunotherapy and targeted therapies for hepatocellular carcinoma: a bibliometric study
by: Biling Gan, et al.
Published: (2025-02-01)